Results 31 to 40 of about 8,300,360 (253)

Relative Biological Effectiveness Variation Along Monoenergetic and Modulated Bragg Peaks of a 62-MeV Therapeutic Proton Beam: A Preclinical Assessment [PDF]

open access: yes, 2014
iological optimization of proton therapy critically depends on detailed evaluation of relative biological effectiveness (RBE) variations along the Bragg curve.
Romano, Francesco   +28 more
core   +1 more source

Cost-effectiveness of biological treatment of ulcerative colitis – a systematic review [PDF]

open access: yes, 2017
The aim of this systematic review was to collect and summarise all current data on the cost-effectiveness of biological treatment in ulcerative colitis.
Stawowczyk, Ewa   +3 more
core   +1 more source

In vitro measurement of proton RBE: A multi-centric comparison using a harmonized setup

open access: yesClinical and Translational Radiation Oncology
Background and purpose: This study presents a multi-center comparison of in vitro cell survival measurements and RBE calculations following proton irradiations conducted under harmonized experimental conditions across six European institutions ...
Olga Sokol   +28 more
doaj   +1 more source

Repeatability and Reproducibility of Microdosimetry With a Mini-TEPC

open access: yesFrontiers in Physics, 2021
Experimental microdosimetry measures the energy deposited in a microscopic sensitive volume (SV) by single ionizing particles traversing the SV or passing by.
A. Bianchi   +10 more
doaj   +1 more source

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine   +17 more
wiley   +1 more source

Comparative Drug Response Profiling in Neuroblastoma Cell Lines and Patient‐Derived Tumor Organoids

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT High‐risk neuroblastoma remains a leading cause of pediatric cancer mortality, and improved preclinical models are needed to guide therapeutic developments. We screened seven high‐risk neuroblastoma cell lines and three patient‐derived tumor organoids with 528 compounds alongside bone marrow controls, and compared them with external datasets ...
Krzysztof Wierbiłowicz   +12 more
wiley   +1 more source

Microdosimetry test on double layer beam shaping assembly neutron beam as a boron neutron capture therapy neutron source using PHITS code [PDF]

open access: yesЯдерна фізика та енергетика
A microdosimetry test on a double layer beam shaping assembly (DLBSA) neutron beam has been carried out using the particle and heavy ion transport code system (PHITS).
Bilalodin   +5 more
doaj   +1 more source

Referral Patterns and Diagnostic Timeliness in Pediatric Cancer: A Hospital‐Based Study in Indonesia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background Timely diagnosis and treatment are critical for improving survival among children with cancer. In low‐ and middle‐income countries (LMICs), delays are common and may be influenced by fragmented referral pathways and diagnostic limitations.
Nur Melani Sari   +5 more
wiley   +1 more source

Effect of relative biological effectiveness as a function of the cell-specific repair rate (a + c) (T = 60 min).

open access: yes, 2018
Effect of relative biological effectiveness as a function of the cell-specific repair rate (a + c) (T = 60 min).
Daisuke Kawahara (6000239)   +4 more
core   +1 more source

Venetoclax‐Based Therapy as a Bridge to Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Pediatric Acute Leukemia

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Relapsed and/or refractory (R/R) pediatric acute leukemia carries a dismal prognosis, largely driven by chemoresistance to conventional salvage therapy. The BH3‐mimetic venetoclax, combined with chemotherapy or hypomethylating agents, has demonstrated efficacy in small clinical trials.
Katherine S. Colman   +9 more
wiley   +1 more source

Home - About - Disclaimer - Privacy